Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
2.020
+0.040 (2.02%)
Jan 14, 2025, 4:00 PM EST - Market closed
Harvard Bioscience Employees
As of December 31, 2023, Harvard Bioscience had 416 total employees, including 391 full-time and 25 part-time employees. The number of employees decreased by 39 or -8.57% compared to the previous year.
Employees
416
Change (1Y)
-39
Growth (1Y)
-8.57%
Revenue / Employee
$234,933
Profits / Employee
-$34,233
Market Cap
88.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
HBIO News
- 1 day ago - Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference - GlobeNewsWire
- 2 months ago - Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET - GlobeNewsWire
- 4 months ago - Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting - GlobeNewsWire
- 4 months ago - Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference - GlobeNewsWire
- 5 months ago - Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Harvard Bioscience Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET - GlobeNewsWire